OCULAR THERAPEUTIX, INC - OCUL

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Deep Track Capital, LP 9.53% 20,850,000 View
May 15, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 9.53% 20,850,000 View
May 15, 2026 SCHEDULE 13G/A David Kroin 9.53% 20,850,000 View
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 17, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners III, L.P. 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Co-Investment Holdings III, LLC 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A Venrock Healthcare Capital Partners EG, L.P. 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Management III, LLC 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A VHCP Management EG, LLC 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A Nimish Shah 3.2% 6,862,972 View
Feb 17, 2026 SCHEDULE 13G/A Bong Y. Koh 3.2% 6,862,972 View
Feb 10, 2026 SCHEDULE 13G Deep Track Capital, LP 5.13% 11,234,132 View
Feb 10, 2026 SCHEDULE 13G Deep Track Biotechnology Master Fund, Ltd. 5.13% 11,234,132 View
Feb 10, 2026 SCHEDULE 13G David Kroin 5.13% 11,234,132 View
Feb 10, 2026 SCHEDULE 13G/A Deep Track Capital, LP 4.31% 9,234,132 View
Feb 10, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 4.31% 9,234,132 View
Feb 10, 2026 SCHEDULE 13G/A David Kroin 4.31% 9,234,132 View
Dec 08, 2025 SCHEDULE 13G SUMMER ROAD LLC 5.7% 12,134,357 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.